Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Non Operating Income (2019 - 2025)

Biodesix's Non Operating Income history spans 7 years, with the latest figure at -$8.0 million for Q4 2025.

  • For Q4 2025, Non Operating Income rose 4.86% year-over-year to -$8.0 million; the TTM value through Dec 2025 reached -$9.5 million, up 25.22%, while the annual FY2025 figure was -$7.4 million, 12.34% up from the prior year.
  • Non Operating Income reached -$8.0 million in Q4 2025 per BDSX's latest filing, down from -$1.7 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $1.6 million in Q3 2021 to a low of -$10.8 million in Q4 2023.
  • Average Non Operating Income over 5 years is -$2.9 million, with a median of -$2.0 million recorded in 2023.
  • Peak YoY movement for Non Operating Income: crashed 415.09% in 2022, then soared 253.12% in 2025.
  • A 5-year view of Non Operating Income shows it stood at -$1.6 million in 2021, then plummeted by 302.25% to -$6.4 million in 2022, then crashed by 67.62% to -$10.8 million in 2023, then rose by 22.69% to -$8.4 million in 2024, then increased by 4.86% to -$8.0 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Non Operating Income are -$8.0 million (Q4 2025), -$1.7 million (Q3 2025), and $51000.0 (Q2 2025).